PAMELA RALLS: Open Payments
NPI 1023252541 · CARROLLTON, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$402 in 20 payments from 11 companies in 2025. Trend: 2023 $485 · 2024 $207 · 2025 $402
Food & beverage: $402
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 4 | $105 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $64 |
| E.R. Squibb & Sons, L.L.C. | 2 | $36 |
| Novartis Pharmaceuticals Corporation | 2 | $34 |
| ABBVIE INC. | 2 | $33 |
| Lundbeck LLC | 2 | $31 |
| SANOFI-AVENTIS U.S. LLC | 1 | $28 |
| Otsuka America Pharmaceutical, Inc. | 1 | $19 |
| AstraZeneca Pharmaceuticals LP | 1 | $17 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $17 |
Products named: Veozah, COBENFY, LEQVIO, QULIPTA, REXULTI, TZIELD, ABILIFY ASIMTUFII, AIRSUPRA.
Industry payments across MO — which companies pay providers there.
